Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability
- PMID: 30615093
- DOI: 10.1093/brain/awy326
Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability
Abstract
Ion channel mutations can cause distinct neuropsychiatric diseases. We first studied the biophysical and neurophysiological consequences of four mutations in the human Na+ channel gene SCN8A causing either mild (E1483K) or severe epilepsy (R1872W), or intellectual disability and autism without epilepsy (R1620L, A1622D). Only combined electrophysiological recordings of transfected wild-type or mutant channels in both neuroblastoma cells and primary cultured neurons revealed clear genotype-phenotype correlations. The E1483K mutation causing mild epilepsy showed no significant biophysical changes, whereas the R1872W mutation causing severe epilepsy induced clear gain-of-function biophysical changes in neuroblastoma cells. However, both mutations increased neuronal firing in primary neuronal cultures. In contrast, the R1620L mutation associated with intellectual disability and autism-but not epilepsy-reduced Na+ current density in neuroblastoma cells and expectedly decreased neuronal firing. Interestingly, for the fourth mutation, A1622D, causing severe intellectual disability and autism without epilepsy, we observed a dramatic slowing of fast inactivation in neuroblastoma cells, which induced a depolarization block in neurons with a reduction of neuronal firing. This latter finding was corroborated by computational modelling. In a second series of experiments, we recorded three more mutations (G1475R, M1760I, G964R, causing intermediate or severe epilepsy, or intellectual disability without epilepsy, respectively) that revealed similar results confirming clear genotype-phenotype relationships. We found intermediate or severe gain-of-function biophysical changes and increases in neuronal firing for the two epilepsy-causing mutations and decreased firing for the loss-of-function mutation causing intellectual disability. We conclude that studies in neurons are crucial to understand disease mechanisms, which here indicate that increased or decreased neuronal firing is responsible for distinct clinical phenotypes.
Similar articles
-
Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.Brain. 2022 Sep 14;145(9):2991-3009. doi: 10.1093/brain/awab321. Brain. 2022. PMID: 34431999 Free PMC article.
-
In vitro effects of eslicarbazepine (S-licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders.Br J Pharmacol. 2023 Apr;180(8):1038-1055. doi: 10.1111/bph.15981. Epub 2022 Dec 19. Br J Pharmacol. 2023. PMID: 36321697
-
De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.J Med Genet. 2015 May;52(5):330-7. doi: 10.1136/jmedgenet-2014-102813. Epub 2015 Feb 27. J Med Genet. 2015. PMID: 25725044 Free PMC article.
-
SCN8A encephalopathy: Mechanisms and models.Epilepsia. 2019 Dec;60 Suppl 3(Suppl 3):S86-S91. doi: 10.1111/epi.14703. Epilepsia. 2019. PMID: 31904118 Free PMC article. Review.
-
Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.Mol Genet Genomic Med. 2022 May;10(5):e1911. doi: 10.1002/mgg3.1911. Epub 2022 Mar 29. Mol Genet Genomic Med. 2022. PMID: 35348308 Free PMC article. Review.
Cited by
-
Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review.Front Pharmacol. 2020 Aug 18;11:1276. doi: 10.3389/fphar.2020.01276. eCollection 2020. Front Pharmacol. 2020. PMID: 33013363 Free PMC article. Review.
-
Carvedilol increases seizure resistance in a mouse model of SCN8A-derived epilepsy.Front Pharmacol. 2024 Jun 4;15:1397225. doi: 10.3389/fphar.2024.1397225. eCollection 2024. Front Pharmacol. 2024. PMID: 38895634 Free PMC article.
-
Voltage Gated Sodium Channel Genes in Epilepsy: Mutations, Functional Studies, and Treatment Dimensions.Front Neurol. 2021 Mar 24;12:600050. doi: 10.3389/fneur.2021.600050. eCollection 2021. Front Neurol. 2021. PMID: 33841294 Free PMC article. Review.
-
SCN8A Encephalopathy: Case Report and Literature Review.Neurol Int. 2021 Apr 1;13(2):143-150. doi: 10.3390/neurolint13020014. Neurol Int. 2021. PMID: 33915942 Free PMC article.
-
Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease.Front Pharmacol. 2021 Nov 17;12:748415. doi: 10.3389/fphar.2021.748415. eCollection 2021. Front Pharmacol. 2021. PMID: 34867351 Free PMC article.